These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29722190)

  • 1. Buruli (Bairnsdale) ulcer in the setting of long-term adalimumab treatment for Crohn disease.
    Freckelton J; Holt D; Sandhu M; Prideaux L; Moore GT
    Intern Med J; 2018 May; 48(5):603-604. PubMed ID: 29722190
    [No Abstract]   [Full Text] [Related]  

  • 2. Extra-pulmonary Reactivation of Latent Tuberculosis After Initiation of Anti-tumour Necrosis Factor Therapy for Inflammatory Bowel Disease-Are Current Screening Strategies Adequate?
    Tranah TH; Luk SY; Gess M
    J Crohns Colitis; 2017 Jun; 11(6):762-763. PubMed ID: 27932451
    [No Abstract]   [Full Text] [Related]  

  • 3. Henoch-Schönlein purpura during anti-TNFα therapy: a fortuitous event or an indication to stop therapy?
    Pinheiro RR; Lencastre A
    Eur J Dermatol; 2017 Jun; 27(3):304-305. PubMed ID: 28468732
    [No Abstract]   [Full Text] [Related]  

  • 4. Growth and bone health in paediatric patients with Crohn's disease receiving subcutaneous tumor necrosis factor antibody.
    Pichler J; Huber WD; Aufricht C; Bidmon-Fliegenschnee B
    World J Gastroenterol; 2015 Jun; 21(21):6613-20. PubMed ID: 26074699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous Vasculitis Caused by Anti-Tumor Necrosis Factor Therapy: A Case Report.
    Shivaji UN; Awasthi AK; Aherne R
    Clin Gastroenterol Hepatol; 2016 Jan; 14(1):e1-2. PubMed ID: 25998787
    [No Abstract]   [Full Text] [Related]  

  • 6. Short report: Clinical and molecular evidence for a case of Buruli ulcer (Mycobacterium ulcerans infection) in Kenya.
    Walsh DS; Eyase F; Onyango D; Odindo A; Otieno W; Waitumbi JN; Bulimo WD; Schnabel DC; Meyers WM; Portaels F
    Am J Trop Med Hyg; 2009 Dec; 81(6):1110-3. PubMed ID: 19996445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Outcomes of Adalimumab Treatment in 254 Patients with Crohn's Disease: A Hospital-Based Cohort Study from Korea.
    Seo H; Ye BD; Song EM; Lee SH; Chang K; Lee HS; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK
    Dig Dis Sci; 2017 Oct; 62(10):2882-2893. PubMed ID: 28822006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buruli ulcer caused by "Mycobacterium ulcerans subsp. shinshuense".
    Watanabe T; Ohkusu K; Nakanaga K; Ishii N; Nakashima K; Shindo M; Yoshida Y; Yamamoto O
    Eur J Dermatol; 2010; 20(6):809-10. PubMed ID: 20822972
    [No Abstract]   [Full Text] [Related]  

  • 9. Adalimumab-induced psoriatic alopecia/alopecia areata-like reaction in a patient with Crohn's disease.
    Toda-Brito H; Lopes L; Soares-Almeida L; Filipe P
    Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buruli ulcer in traveler from Suriname, South America, to the Netherlands.
    Faber WR; de Jong B; de Vries HJ; Zeegelaar JE; Portaels F
    Emerg Infect Dis; 2015 Mar; 21(3):497-9. PubMed ID: 25695367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV infection and Buruli ulcer in Africa.
    Vincent QB; Ardant MF; Marsollier L; Chauty A; Alcaïs A;
    Lancet Infect Dis; 2014 Sep; 14(9):796-7. PubMed ID: 25164193
    [No Abstract]   [Full Text] [Related]  

  • 12. Buruli ulcer: Advances in understanding Mycobacterium ulcerans infection.
    Walsh DS; Portaels F; Meyers WM
    Dermatol Clin; 2011 Jan; 29(1):1-8. PubMed ID: 21095521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple and fulminant cutaneous squamous cell carcinomas in a Crohn's disease patient treated with immunosuppressants and adalimumab.
    Nancey S; Boschetti G; Cotte E; Cathey-Javouhay A; Laidet M; Chichery A; Francois Y; Glehen O; Flourié B
    Inflamm Bowel Dis; 2011 Apr; 17(4):1060-1. PubMed ID: 21391289
    [No Abstract]   [Full Text] [Related]  

  • 14. Buruli Ulcer Successfully Treated With Negative-Pressure Wound Therapy.
    Murase C; Kono M; Nakanaga K; Ishii N; Akiyama M
    JAMA Dermatol; 2015 Oct; 151(10):1137-9. PubMed ID: 26106826
    [No Abstract]   [Full Text] [Related]  

  • 15. Buruli ulcer in an 18-day-old baby.
    Kiiza AM; Wood PB
    Trop Doct; 2012 Jan; 42(1):48. PubMed ID: 22080481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buruli ulcer acquired in Mali: a rare and atypical situation.
    Vignier N; Kempf M; Vignes D; Gousseff M; Alexandre M; Mechaï F; Marsollier L; Bouchaud O
    Travel Med Infect Dis; 2014; 12(6 Pt B):781-2. PubMed ID: 25316623
    [No Abstract]   [Full Text] [Related]  

  • 17. To Buruli or not to Buruli.
    Ho L; Cohn J; Comte E
    Trop Doct; 2013 Apr; 43(2):92. PubMed ID: 23796682
    [No Abstract]   [Full Text] [Related]  

  • 18. [Infection with mycobacterium ulcerans (Buruli ulcer): still a neglected disease in 2009?].
    Françoise P
    Med Trop (Mars); 2009 Oct; 69(5):429-30. PubMed ID: 20025166
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of tumor necrosis factor-α antagonists on oxidative stress in patients with Crohn's disease.
    Yamamoto K; Chiba T; Matsumoto T
    World J Gastroenterol; 2015 Sep; 21(35):10208-14. PubMed ID: 26401086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term adalimumab treatment of hidradenitis suppurativa: Results and practical insights from a real-life experience.
    Bettoli V; Manfredini M; Calamo G; Forconi R; Bencivelli D; Mantovani L; Pellacani G; Corazza M
    Dermatol Ther; 2018 Nov; 31(6):e12737. PubMed ID: 30295378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.